Close Menu

NEW YORK (GenomeWeb) – Quanterix reported after the close of the market on Wednesday that its first quarter revenues were up 64 percent year over year.

The company posted Q1 revenues of $12.3 million, up from $7.5 million in Q1 2018 and above the consensus Wall Street estimate of $10.2 million.

Its Q1 product revenues rose 102 percent to $9.5 million in Q1 2018 from $4.7 million in Q1 2018, with consumables sales up 124 percent and instrument sales up 70 percent. Service and other revenues rose 11 percent to $2.8 million from $2.5 million in the prior-year first quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.